FDA label ea3b06a7-0cb5-460f-ab1c-519892c792ed

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

SPL set ID
7715891a-a1bc-449d-a87e-befdc08532bc
SPL ID
ea3b06a7-0cb5-460f-ab1c-519892c792ed
Version
3
Effective date
2012-06-29
Source export date
2026-10-12
Source partition
3
Source file
https://download.open.fda.gov/drug/label/drug-label-0003-of-0014.json.zip
Source object key
raw/openfda/drug-label/2026-10-12/f40eac55ff4c5d55c3d8bbc5766ea7e21e4196960cfb4703b96a406b491c0cd5/drug-label-0003-of-0014.json.zip
Source manifest SHA-256
7e6b178df8f32cac9a78e0f5d09c588344509b04fe41effb1dde9102e2a45be6
Import run
20261013T011858Z
Imported at
2026-10-13 01:33:56

Adverse reactions cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Adverse reactions sections page 1 of 1 · 2 matching rows.

adverse reactions

ADVERSE REACTIONS The following local adverse reactions are reported infrequently with topical corticosteroids, but may occur more frequently with the use of occlusive dressings. These reactions are listed in an approximate decreasing order of occurrence. Burning Hypertrichosis Maceration of the skin Itching Acneiform eruption Secondary infection Irritation Hypopigmentation Skin atrophy Dryness Perioral dermatitis Striae Folliculitis Allergic contact dermatitis Miliaria

adverse reactions table

<table border="1" width="439" ID="inv-6a8ef458-30b4-4df2-bd34-3b93a6948dc9"> <col width="25.1%"/> <col width="38.7%"/> <col width="36.2%"/> <tbody> <tr ID="id_c4ef5923-edac-4b9c-ad4d-da82138d8586"> <td align="left" valign="top" styleCode="Botrule Toprule Rrule Lrule">Burning</td> <td align="left" valign="top" styleCode="Botrule Rrule">Hypertrichosis</td> <td align="left" valign="top" styleCode="Botrule Toprule Rrule Lrule">Maceration of the skin</td> </tr> <tr ID="id_3d31cf57-da1d-4e69-9111-41056f6ac89a"> <td align="left" valign="middle" styleCode="Lrule Botrule Rrule">Itching</td> <td align="left" valign="middle" styleCode="Botrule Rrule">Acneiform eruption</td> <td align="left" valign="middle" styleCode="Botrule Rrule">Secondary infection</td> </tr> <tr ID="id_21085832-3c60-4d9f-b1f1-44d5a4627840"> <td align="left" valign="middle" styleCode="Lrule Botrule Rrule">Irritation</td> <td align="left" valign="middle" styleCode="Botrule Rrule">Hypopigmentation</td> <td align="left" valign="middle" styleCode="Botrule Rrule">Skin atrophy</td> </tr> <tr ID="id_180004bc-5139-4979-93de-74b3f087ee76"> <td align="left" valign="middle" styleCode="Lrule Botrule Rrule">Dryness</td> <td align="left" valign="middle" styleCode="Botrule Rrule">Perioral dermatitis</td> <td align="left" valign="middle" styleCode="Botrule Rrule">Striae</td> </tr> <tr ID="id_78fe80d9-0131-4621-a7b6-68d6e5ab1a5b"> <td align="left" valign="middle" styleCode="Lrule Botrule Rrule">Folliculitis</td> <td align="left" valign="middle" styleCode="Rrule">Allergic contact dermatitis</td> <td align="left" valign="middle" styleCode="Botrule Rrule">Miliaria</td> </tr> </tbody> </table>

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.